Literature DB >> 32418842

Early life stress and glutamate neurotransmission in major depressive disorder.

Lynnette A Averill1, Chadi G Abdallah2, Lisa R Fenton3, Madonna K Fasula4, Lihong Jiang5, Douglas L Rothman5, Graeme F Mason6, Gerard Sanacora4.   

Abstract

Early life stress (ELS) and glutamate neurotransmission have been implicated in the pathophysiology of major depressive disorder (MDD). In non-human primates, ELS was positively correlated with cortical Glx (i.e., glutamate + glutamine). However, the relationship between ELS and cortical glutamate in adult patients with MDD is not fully known. Using 1H Magnetic Resonance Spectroscopy (MRS), we conducted exploratory analyses measuring occipital cortical glutamate and glutamine levels in 36 medication-free patients with MDD. In a subsample (n=11), we measured dynamic glutamate/glutamine cycling (Vcycle) using advanced 13C MRS methods. ELS history was assessed using Early-life Trauma Inventory (ETI). Exploratory analyses suggest a relationship between ETI and glutamine as reflected by a significant positive correlation between ETI scores and occipital glutamine (rs=0.39, p=0.017) but not glutamate. Post-hoc analyses showed that the association with glutamine was driven by the ETI emotional abuse (ETI-EA) subscale (rs=0.39, p=0.02). Vcycle correlation with ETI was at trend level (rs=0.55, p=0.087) and significantly correlated with ETI-EA (rs=0.67, p=0.03). In this small sample of patients with MDD, those with childhood emotional abuse appear to have increased occipital glutamate neurotransmission as reflected by increased glutamate/glutamine cycling and glutamine level. Future studies would be needed to confirm this pilot evidence and to examine whether ELS effects on glutamate neurotransmission underlie the relationship between ELS and psychopathology. Published by Elsevier B.V.

Entities:  

Keywords:  Early life stress; Emotional abuse; Glutamate; Glutamine; Magnetic resonance spectroscopy (MRS); Major depressive disorder (MDD)

Year:  2020        PMID: 32418842      PMCID: PMC7913468          DOI: 10.1016/j.euroneuro.2020.03.015

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  74 in total

Review 1.  The Links Between Stress and Depression: Psychoneuroendocrinological, Genetic, and Environmental Interactions.

Authors:  Gustavo E Tafet; Charles B Nemeroff
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2015-11-09       Impact factor: 2.198

2.  Emotional abuse in childhood is a differential factor for the development of depression in adults.

Authors:  Camila Maria Severi Martins; Cristiane Von Werne Baes; Sandra Marcia de Carvalho Tofoli; Mario Francisco Juruena
Journal:  J Nerv Ment Dis       Date:  2014-11       Impact factor: 2.254

3.  Long-term effect of combined interpersonal psychotherapy and pharmacotherapy in a randomized trial of depressed patients.

Authors:  I Zobel; S Kech; D van Calker; P Dykierek; M Berger; R Schneibel; E Schramm
Journal:  Acta Psychiatr Scand       Date:  2011-01-14       Impact factor: 6.392

4.  Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors.

Authors:  Gerard Sanacora; Graeme F Mason; Douglas L Rothman; John H Krystal
Journal:  Am J Psychiatry       Date:  2002-04       Impact factor: 18.112

5.  Differences in excitatory and inhibitory neurotransmitter levels between depressed patients and healthy controls: A systematic review and meta-analysis.

Authors:  Kate E M Godfrey; Abby C Gardner; Sarah Kwon; William Chea; Suresh D Muthukumaraswamy
Journal:  J Psychiatr Res       Date:  2018-08-11       Impact factor: 4.791

6.  Cerebrospinal fluid corticotropin-releasing factor and perceived early-life stress in depressed patients and healthy control subjects.

Authors:  Linda L Carpenter; Audrey R Tyrka; Christopher J McDougle; Robert T Malison; Michael J Owens; Charles B Nemeroff; Lawrence H Price
Journal:  Neuropsychopharmacology       Date:  2004-04       Impact factor: 7.853

Review 7.  Astrocyte pathology in major depressive disorder: insights from human postmortem brain tissue.

Authors:  Grazyna Rajkowska; Craig A Stockmeier
Journal:  Curr Drug Targets       Date:  2013-10       Impact factor: 3.465

8.  Glutamate normalization with ECT treatment response in major depression.

Authors:  J Zhang; K L Narr; R P Woods; O R Phillips; J R Alger; R T Espinoza
Journal:  Mol Psychiatry       Date:  2012-05-08       Impact factor: 15.992

9.  Effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse or recurrence (PREVENT): a randomised controlled trial.

Authors:  Willem Kuyken; Rachel Hayes; Barbara Barrett; Richard Byng; Tim Dalgleish; David Kessler; Glyn Lewis; Edward Watkins; Claire Brejcha; Jessica Cardy; Aaron Causley; Suzanne Cowderoy; Alison Evans; Felix Gradinger; Surinder Kaur; Paul Lanham; Nicola Morant; Jonathan Richards; Pooja Shah; Harry Sutton; Rachael Vicary; Alice Weaver; Jenny Wilks; Matthew Williams; Rod S Taylor; Sarah Byford
Journal:  Lancet       Date:  2015-04-20       Impact factor: 79.321

10.  Reduced cortical thickness in veterans exposed to early life trauma.

Authors:  Vincent Corbo; David H Salat; Melissa M Amick; Elizabeth C Leritz; William P Milberg; Regina E McGlinchey
Journal:  Psychiatry Res       Date:  2014-05-02       Impact factor: 3.222

View more
  3 in total

1.  Combination of electroconvulsive stimulation with ketamine or escitalopram protects the brain against inflammation and oxidative stress induced by maternal deprivation and is critical for associated behaviors in male and female rats.

Authors:  Helena M Abelaira; Thayse Rosa; Airam B de Moura; Natalia M Andrade; Nicoly S Martinello; Larissa R Maciel; Maria Eduarda M Botelho; Laura A Borba; Beatriz C Chede; Camila O Arent; Larissa Joaquim; Sandra Bonfante; Lucinéia G Danielski; Talita Tuon; Fabricia Petronilho; João Quevedo; Gislaine Z Réus
Journal:  Mol Neurobiol       Date:  2022-01-07       Impact factor: 5.590

2.  A pilot spectroscopy study of adversity in adolescents.

Authors:  A Irem Sonmez; Charles P Lewis; John D Port; Arjun P Athreya; Doo-Sop Choi; Michael J Zaccariello; Julia Shekunov; Caren J Blacker; Paul E Croarkin
Journal:  Biomark Neuropsychiatry       Date:  2021-10-02

Review 3.  Cell-type-specific epigenetic effects of early life stress on the brain.

Authors:  Mouly F Rahman; Patrick O McGowan
Journal:  Transl Psychiatry       Date:  2022-08-10       Impact factor: 7.989

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.